Shilpa Medicare (NSE:SHILPAMED) E10: ₹7.87 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SHILPAMED Shilpa Medicare Ltd NSE:SHILPAMED
72 GF Score
Price ₹889.70
GF Value ₹455.27
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Shilpa Medicare E10?

Shilpa Medicare NSE:SHILPAMED -6.28% 72 E10 is ₹7.87 as of Jun. 2026. GuruFocus rates NSE:SHILPAMED with a GF Score™ of 72/100 and a GF Value™ of ₹455.27 (Significantly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shilpa Medicare's adjusted earnings per share data for the three months ended in Jun. 2026 was ₹5.160. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹7.87 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Shilpa Medicare's average E10 Growth Rate was 9.50% per year. During the past 3 years, the average E10 Growth Rate was -1.00% per year. During the past 5 years, the average E10 Growth Rate was -2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Shilpa Medicare was 1.40% per year. The lowest was -4.40% per year. And the median was -1.85% per year.

As of today (2026-09-02), Shilpa Medicare's current stock price is ₹889.70. Shilpa Medicare's E10 for the quarter that ended in Jun. 2026 was ₹7.87. Shilpa Medicare's Shiller PE Ratio of today is 113.05.

During the past 13 years, the highest Shiller PE Ratio of Shilpa Medicare was 114.91. The lowest was 15.09. And the median was 34.16.


Shilpa Medicare  (NSE:SHILPAMED) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shilpa Medicare's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=889.70/7.87
=113.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Shilpa Medicare was 114.91. The lowest was 15.09. And the median was 34.16.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Shilpa Medicare E10 Related Terms


Shilpa Medicare E10 Historical Data

* Premium members only.

The historical data trend for Shilpa Medicare's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shilpa Medicare E10 Chart

Shilpa Medicare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.06 7.58 7.23 7.02 7.38

Shilpa Medicare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.26 7.16 7.17 7.38 7.87

NSE:SHILPAMED vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shilpa Medicare's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shilpa Medicare Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shilpa Medicare's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shilpa Medicare's Shiller PE Ratio falls into.


NSE:SHILPAMED
72GF Score
Shilpa Medicare Ltd NSE:SHILPAMED
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shilpa Medicare E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shilpa Medicare's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=5.16/167.3573*167.3573
=5.160

Current CPI (Jun. 2026) = 167.3573.

Shilpa Medicare Quarterly Data

per share eps CPI Adj_EPS
201609 2.485 105.961 3.925
201612 1.015 105.196 1.615
201703 2.165 105.196 3.444
201706 1.385 107.109 2.164
201709 2.105 109.021 3.231
201712 1.061 109.404 1.623
201803 1.970 109.786 3.003
201806 2.065 111.317 3.105
201809 2.590 115.142 3.765
201812 0.765 115.142 1.112
201903 1.465 118.202 2.074
201906 0.965 120.880 1.336
201909 3.115 123.175 4.232
201912 3.375 126.235 4.474
202003 2.120 124.705 2.845
202006 5.295 127.000 6.978
202009 2.785 130.118 3.582
202012 0.470 130.889 0.601
202103 0.520 131.771 0.660
202106 0.095 134.084 0.119
202109 1.225 135.847 1.509
202112 0.565 138.161 0.684
202203 1.745 138.822 2.104
202206 0.050 142.347 0.059
202209 -1.075 144.661 -1.244
202212 -0.380 145.763 -0.436
202303 -0.470 146.865 -0.536
202306 0.070 150.280 0.078
202309 0.095 151.492 0.105
202312 0.265 152.924 0.290
202403 1.410 153.035 1.542
202406 0.730 155.789 0.784
202409 0.460 157.882 0.488
202412 1.630 158.323 1.723
202503 0.740 157.552 0.786
202506 2.400 159.755 2.514
202509 1.125 162.289 1.160
202512 2.360 163.281 2.419
202603 5.510 164.272 5.613
202606 5.160 167.357 5.160

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹7.87 mean?
Shilpa Medicare (NSE:SHILPAMED) has a E10 of ₹7.87 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Shilpa Medicare and its competitors.
Is Shilpa Medicare's E10 too high?
Shilpa Medicare's current E10 is ₹7.87. Overall, Shilpa Medicare has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shilpa Medicare's E10 compare to ZTS?
Shilpa Medicare's E10 of ₹7.87 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Shilpa Medicare and its competitors. Shilpa Medicare's current E10 is ₹7.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shilpa Medicare stock overvalued right now?
Based on GuruFocus' analysis, Shilpa Medicare (NSE:SHILPAMED) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹455.27, compared to a current price of ₹889.70 — trading 95.4% above its estimated fair value. The current E10 is ₹7.87. Shilpa Medicare's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Shilpa Medicare (NSE:SHILPAMED), the current E10 is ₹7.87 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shilpa Medicare (NSE:SHILPAMED) Overvalued in 2026?

Based on GuruFocus' analysis, Shilpa Medicare stock appears to be overvalued. The current stock price of ₹889.70 is trading 95.4% above its estimated GF Value™ of ₹455.27. GuruFocus considers Shilpa Medicare to be Significantly Overvalued.

Key valuation signals for NSE:SHILPAMED:

  • E10: ₹7.87
  • GF Value™: ₹455.27 vs. price of ₹889.70 (95.4% above fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the NSE:SHILPAMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shilpa Medicare Business Description

Other Exchanges 530549:India
Address Hyderabad Road, No. 12-6-214/A-1, Shilpa House, Raichur, KA, IND, 584135
Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company deals in high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery Systems, Peptides, Biotech products, and Specialty Chemicals etc. Its portfolio comprises various oncology and non-oncology-related APIs such as anastrozole, acebrophylline, busulphan, decitabine, etc, and finished dosage formulations such as apremilast tablets, clofarabine injection, docetaxel injection, etc., in various therapy areas. Its reporting segments are: Pharmaceutical product and services, which derive maximum revenue, Power sales, and Others. Geographically, the company generates maximum revenue from India, followed by Europe, the United States of America, and the Rest of the world.
72GF Score

Get the complete analysis for NSE:SHILPAMED

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹889.70
Price
₹455.27
GF Value